compound 3f
oral Factor XIa inhibitor IV efficacy in rabbit AV shunt model from literature starting point and SBDD J. Med. Chem., July 21, 2022 Janssen Research & Development, L.L.C., Spring House, PA
Molecules of the Month - July 2022
4 minute read
Aug. 26, 2022
Compound 3f: an Oral Factor XIa (FXIa) Inhibitor for Thromboembolic Diseases